Cost-effectiveness of Cervical Total Disc Replacement vs Fusion for the Treatment of 2-Level Symptomatic Degenerative Disc Disease | Zendy

Jared D. Ament | Zendy; Zhuo Yang | Zendy; Pierce D. Nunley | Zendy; Marcus B. Stone | Zendy; Kee D. Kim | Zendy

Open Access

Cost-effectiveness of Cervical Total Disc Replacement vs Fusion for the Treatment of 2-Level Symptomatic Degenerative Disc Disease

Author(s) -

Jared D. Ament,

Zhuo Yang,

Pierce D. Nunley,

Marcus B. Stone,

Kee D. Kim

Publication year - 2014

Publication title -

jama surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.757

H-Index - 176

eISSN - 2168-6262

pISSN - 2168-6254

DOI - 10.1001/jamasurg.2014.716

Subject(s) - medicine , anterior cervical discectomy and fusion , randomized controlled trial , visual analogue scale , cervical spondylosis , physical therapy , reimbursement , cost effectiveness , quality adjusted life year , degenerative disc disease , surgery , health care , lumbar , cervical spine , risk analysis (engineering) , alternative medicine , pathology , economic growth , economics

Cervical total disc replacement (CTDR) was developed to treat cervical spondylosis, while preserving motion. While anterior cervical discectomy and fusion (ACDF) has been the standard of care for 2-level disease, a randomized clinical trial (RCT) suggested similar outcomes. Cost-effectiveness of this intervention has never been elucidated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research